Search research articles
Contact Us
Filters
Showing results (111-120 of 156) with videos related to
Page
of 16
Sort By:
Seminars in Hematology
|
May 12, 2023
Report of consensus Panel 4 from the 11th International Workshop on Waldenstrom's macroglobulinemia on diagnostic and response criteria
Steven P Treon, Alessandra Tedeschi, Jesus San-Miguel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 3, 2008
Update on treatment recommendations from the Fourth International Workshop on Waldenstrom's Macroglobulinemia
Meletios Athanasios Dimopoulos, Morie A Gertz, Efstathios Kastritis, et al.
American Journal of Hematology
|
July 18, 2013
Genome wide SNP array identified multiple mechanisms of genetic changes in Waldenstrom macroglobulinemia
Stéphanie Poulain, Christophe Roumier, Sylvie Galiègue-Zouitina, et al.
Plos Genetics
|
June 2, 2012
EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice
Anne-Pierre Morel, George W Hinkal, Clémence Thomas, et al.
Leukemia & Lymphoma
|
April 12, 2017
A phase II Bayesian sequential clinical trial in advanced Waldenström macroglobulinemia patients treated with bortezomib: interest of addition of dexamethasone
Véronique Leblond, Pierre Morel, Marie-Sarah Dilhuidy, et al.
Clinical Lymphoma & Myeloma
|
April 28, 2006
Update on recommendations for assessing response from the Third International Workshop on Waldenstrom's Macroglobulinemia
Eva Kimby, Steven P Treon, Athanasios Anagnostopoulos, et al.
Blood
|
February 29, 2020
A prospective phase 2 trial of daratumumab in patients with previously treated systemic light-chain amyloidosis
Murielle Roussel, Giampaolo Merlini, Sylvie Chevret, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 5, 2025
Waldenström's macroglobulinemia: The LYSA pragmatic guidelines
Damien Roos-Weil, Cécile Tomowiak, Stéphanie Poulain, et al.
Seminars in Hematology
|
May 29, 2025
Report of Consensus Panel 3 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with high-risk disease
Prashant Kapoor, Meletios A Dimopoulos, Stephen M Ansell, et al.
Hematological Oncology
|
November 24, 2016
First-line therapy for chronic lymphocytic leukemia in patients older than 79 years is feasible and achieves good results: A FILO retrospective study
Godelieve Meunier, Loic Ysebaert, Phi Linh Nguyen-Thi, et al.
Page
of 16
Search research articles
Search
Showing results (111-120 of 156) with videos related to
Sort By:
Page
of 16
Seminars in Hematology
|
May 12, 2023
Report of consensus Panel 4 from the 11th International Workshop on Waldenstrom's macroglobulinemia on diagnostic and response criteria
Steven P Treon, Alessandra Tedeschi, Jesus San-Miguel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 3, 2008
Update on treatment recommendations from the Fourth International Workshop on Waldenstrom's Macroglobulinemia
Meletios Athanasios Dimopoulos, Morie A Gertz, Efstathios Kastritis, et al.
American Journal of Hematology
|
July 18, 2013
Genome wide SNP array identified multiple mechanisms of genetic changes in Waldenstrom macroglobulinemia
Stéphanie Poulain, Christophe Roumier, Sylvie Galiègue-Zouitina, et al.
Plos Genetics
|
June 2, 2012
EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice
Anne-Pierre Morel, George W Hinkal, Clémence Thomas, et al.
Leukemia & Lymphoma
|
April 12, 2017
A phase II Bayesian sequential clinical trial in advanced Waldenström macroglobulinemia patients treated with bortezomib: interest of addition of dexamethasone
Véronique Leblond, Pierre Morel, Marie-Sarah Dilhuidy, et al.
Clinical Lymphoma & Myeloma
|
April 28, 2006
Update on recommendations for assessing response from the Third International Workshop on Waldenstrom's Macroglobulinemia
Eva Kimby, Steven P Treon, Athanasios Anagnostopoulos, et al.
Blood
|
February 29, 2020
A prospective phase 2 trial of daratumumab in patients with previously treated systemic light-chain amyloidosis
Murielle Roussel, Giampaolo Merlini, Sylvie Chevret, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 5, 2025
Waldenström's macroglobulinemia: The LYSA pragmatic guidelines
Damien Roos-Weil, Cécile Tomowiak, Stéphanie Poulain, et al.
Seminars in Hematology
|
May 29, 2025
Report of Consensus Panel 3 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with high-risk disease
Prashant Kapoor, Meletios A Dimopoulos, Stephen M Ansell, et al.
Hematological Oncology
|
November 24, 2016
First-line therapy for chronic lymphocytic leukemia in patients older than 79 years is feasible and achieves good results: A FILO retrospective study
Godelieve Meunier, Loic Ysebaert, Phi Linh Nguyen-Thi, et al.
Page
of 16